These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25546788)

  • 1. 7th International Immunoglobulin Conference: Immunomodulation.
    Danieli MG; Shoenfeld Y
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):123. PubMed ID: 25546788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7th International Immunoglobulin Conference: Immunomodulation.
    Danieli MG; Shoenfeld Y
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):112-4. PubMed ID: 25546784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders.
    Omwandho CO; Gruessner SE; Roberts TK; Tinneberg HR
    Clin Chem Lab Med; 2004 Apr; 42(4):359-70. PubMed ID: 15147144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):111. PubMed ID: 25546783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
    Perricone R; De Carolis C; Kröegler B; Greco E; Giacomelli R; Cipriani P; Fontana L; Perricone C
    Rheumatology (Oxford); 2008 May; 47(5):646-51. PubMed ID: 18346976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.
    Lazarus AH
    J Clin Immunol; 2010 May; 30 Suppl 1():S20-3. PubMed ID: 20401687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active or passive immunization in unexplained recurrent miscarriage.
    Christiansen OB; Nielsen HS; Pedersen B
    J Reprod Immunol; 2004 Jun; 62(1-2):41-52. PubMed ID: 15288180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin therapy in dermatologic disorders.
    Cakmak SK; Gül U; Gönül M; Kiliç A; Soylu S
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):75-84. PubMed ID: 18691136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's new in i.v. immunoglobulin therapy and pemphigus: high-dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigus.
    Aoyama Y
    J Dermatol; 2010 Mar; 37(3):239-45. PubMed ID: 20507387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.
    Kazatchkine MD; Kaveri SV
    N Engl J Med; 2001 Sep; 345(10):747-55. PubMed ID: 11547745
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous immunoglobulin G in the treatment of autoimmune bullous disease.
    Czernik A
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):118-9. PubMed ID: 25546786
    [No Abstract]   [Full Text] [Related]  

  • 12. Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases.
    Blank M; Bashi T; Shoenfeld Y
    Methods Mol Biol; 2014; 1060():353-61. PubMed ID: 24037850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction.
    Fuchs S; Feferman T; Meidler R; Margalit R; Sicsic C; Brenner T; Laub O; Souroujon MC
    Ann N Y Acad Sci; 2008; 1132():244-8. PubMed ID: 18567875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7th International Immunoglobulin Conference: Poster presentations.
    Warnatz K; Ballow M; Stangel M; Bril V
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):162. PubMed ID: 25546805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma TNF-α levels are higher in early pregnancy in patients with secondary compared with primary recurrent miscarriage.
    Piosik ZM; Goegebeur Y; Klitkou L; Steffensen R; Christiansen OB
    Am J Reprod Immunol; 2013 Nov; 70(5):347-58. PubMed ID: 23656493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use.
    Caccavo D; Vaccaro F; Ferri GM; Amoroso A; Bonomo L
    J Autoimmun; 1994 Aug; 7(4):537-48. PubMed ID: 7980854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion.
    Achiron A; Margalit R; Hershkoviz R; Markovits D; Reshef T; Melamed E; Cohen IR; Lider O
    J Clin Invest; 1994 Feb; 93(2):600-5. PubMed ID: 8113397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.